trans1
-
Spine
TranS1 gets FDA nod for new spine surgery device
March 24 – Medical device maker TranS1 Inc TSON.O said U.S. health regulators approved a new version of its minimally…
Read More » -
TranS1 Inc. Announces Two Clinical Papers Accepted for Publication, Updates First Quarter 2011 Guidance
WILMINGTON, N.C., March 21, 2011 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and…
Read More » -
Humana to cover TranS1 AxiaLIF
FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date…
Read More » -
TranS1 Announces CEO Transition
WILMINGTON, N.C., Jan. 4, 2011 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON) today announced that its Board of Directors (the “Board”)…
Read More » -
TranS1 Inc. Reports Operating Results for the Second Quarter of 2010, Issues Third Quarter Guidance
WILMINGTON, N.C., Aug. 5, 2010 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and…
Read More » -
TranS1 Inc. Announces AxiaLIF 2L+ Product Launch
WILMINGTON, N.C., Jul 27, 2010 (GlobeNewswire via COMTEX) -- TranS1 Inc. (TSON 2.43, +0.11, +4.74%), a pioneer in novel approaches to lumbar spine…
Read More » -
TranS1, Inc. Q1 2010 Earnings Call Transcript
TranS1, Inc. (TSON) Q1 2010 Earnings Call Transcript May 4, 2010 5:30 pm ET Executives Mark Klausner – IR Rick…
Read More » -
TranS1 Inc. Announces Appointment of Dwayne Montgomery as Vice President of Sales
WILMINGTON, N.C., Mar 18, 2010 (GlobeNewswire via COMTEX) — TranS1 Inc. (TSON 3.41, +0.03, +0.89%), a medical device company focused on designing, developing…
Read More » -
TranS1 Inc. Announces CFO Transition
WILMINGTON, N.C., Feb. 23, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and…
Read More » -
TranS1 Inc. Reports Operating Results for the Fourth Quarter of 2009
Highlights: Fourth quarter revenues were $6.3 million 674 TranS1 procedures performed globally in the quarter Gross margin was 79.9% for…
Read More » -
TranS1 Inc. to Present at the J.P. Morgan Healthcare Conference
WILMINGTON, N.C., Jan. 8, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON) announced today that Richard Randall, Chief Executive Officer, is…
Read More » -
TranS1 Inc. Announces Appointment of Ken Reali as President and Chief Operating Officer
WILMINGTON, N.C., Jan. 7, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON – News), a medical device company focused on designing, developing…
Read More » -
TranS1 Inc. Partners With Life Spine, Inc. to Distribute Avatar(TM), a New Minimally Invasive Pedicle Screw System
WILMINGTON, N.C., Jan. 7, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON) a medical device company focused on designing, developing and…
Read More » -
TranS1 Inc. Announces Preliminary Revenue Results for Fourth Quarter
WILMINGTON, N.C., Jan. 7, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and…
Read More » -
TranS1 Inc. Reports Operating Results for the Third Quarter of 2009
Highlights: Third quarter revenues increased 15% to $6.9 million 729 TranS1 procedures performed globally in the quarter Gross margin was…
Read More »